siRNA and miRNA Gene Silencing : From Bench to Bedside /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
Totowa, NJ :
Humana Press : Imprint: Humana,
2009.
|
| Edición: | 1st ed. 2009. |
| Colección: | Methods in Molecular Biology,
487 |
| Materias: |
Tabla de Contenidos:
- Methods for Selecting Effective siRNA Sequences by using Statistical and Clustering Techniques
- Deciphering the Code of Innate Immunity Recognition of siRNAs
- Targeted Delivery of Antisense Oligonucleotides and siRNAs into Mammalian Cells
- Local and Systemic Delivery of siRNAs for Oligonucleotides Therapy
- Imaging of siRNA Delivery and Silencing
- Recent Advances in Magnetofection and Its Potential to Deliver siRNAs In Vitro
- In Vitro and In Vivo Gene Silencing by TransKingdom RNAi (tkRNAi)
- Bacterial Delivery of siRNAs: A New Approach to Solid Tumor Therapy
- The Therapeutic Potential of LNA-modified siRNAs: Reduction of Off-target Effects by Chemical Modification of the siRNA Sequence
- pSM155 and pSM30 Vectors for miRNA and shRNA Expression
- Targeting Oncogenes with siRNAs
- Targeting Stromal-cancer Cell Interactions with siRNAs
- Therapeutic Potential of siRNA-mediated Targeting of Urokinase Plasminogen Activator, Its Receptor, and Matrix Metalloproteinases
- Silencing of HIF-1#x03B1; by RNA Interference in Human Glioma Cells In Vitro and In Vivo
- RNA Interference-Mediated Validation of Genes Involved in Telomere Maintenance and Evasion of Apoptosis as Cancer Therapeutic Targets
- Treating Respiratory Viral Diseases with Chemically Modified, Second Generation Intranasal siRNAs
- Progress in the Therapeutic Applications of siRNAs Against HIV-1
- Protein Components of the microRNA Pathway and Human Diseases
- Intron-Mediated RNA Interference and microRNA Biogenesis
- Emergence of a Complex Relationship between HIV-1 and the microRNA Pathway
- Synthetic microRNA Targeting Glioma-associated Antigen-1 Protein
- Therapeutic Targeting of Gene Expression by siRNAs Directed Against BCR-ABL Transcripts in a Patient with Imatinib-Resistant Chronic Myeloid Leukemia.